BioCentury
ARTICLE | Company News

Exact Sciences, CMS sales and marketing update

February 9, 2015 8:00 AM UTC

Exact Sciences said CMS updated its 2015 reimbursement rate for Exact’s Cologuard colon cancer diagnostic to $492.72 per test. The non-invasive stool DNA test utilizes a multiplexed quantitative Inva...